Lin Zhong, Wang Yu, Li Dong, Wen Liang, Zhai Gang, Ding Xiao Xia, Zang Dong Xiao, Wang Feng Hua, Liang Yuan Bo
The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China.
National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China.
Jpn J Ophthalmol. 2022 Jan;66(1):102-109. doi: 10.1007/s10384-021-00877-x. Epub 2021 Oct 16.
To investigate the association between metabolic syndrome (MetS) and diabetic retinopathy (DR), as well as the association between MetS and retinal vessel caliber, among Chinese patients with type 2 diabetes mellitus in north-eastern China.
Cross-sectional study.
The patients were recruited from a community-based study, the Fushun Diabetic Retinopathy Cohort Study (FS-DIRECT). The presence of DR was determined using a modified version of the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. The central retinal arteriolar equivalent (CRAE) and the central retinal venular equivalent (CRVE) were identified by use of Integrative Vessel Analysis software. The presence of MetS was defined according to the Joint Interim Statement proposed in 2009.
The prevalence of DR was significantly higher among female patients with MetS than among those without it (47.2% vs 30.9%, P = 0.002), and it increased as the number of MetS components increased (P = 0.003). Furthermore, the presence of MetS (odds ratio 2.43, 95% CI 1.39-4.26) as well as higher numbers of MetS components were significantly associated with DR in female patients, after adjustment for potential risk factors. Patients with MetS (multivariate β coefficient, 95% CI - 6.9, - 10.0, to - 3.8) or a higher number of Mets components tended to have significantly smaller CRAE.
In this study cohort, female patients with MetS had a higher prevalence of DR. Patients tended to have thinner central retinal arterioles as the number of MetS components increased.
在中国东北地区2型糖尿病患者中,研究代谢综合征(MetS)与糖尿病视网膜病变(DR)之间的关联,以及MetS与视网膜血管管径之间的关联。
横断面研究。
患者来自一项基于社区的研究——抚顺糖尿病视网膜病变队列研究(FS-DIRECT)。使用改良版早期糖尿病视网膜病变研究(ETDRS)量表确定DR的存在情况。通过综合血管分析软件识别视网膜中央动脉等效直径(CRAE)和视网膜中央静脉等效直径(CRVE)。根据2009年提出的联合临时声明定义MetS的存在情况。
患有MetS的女性患者中DR的患病率显著高于未患MetS的女性患者(47.2%对30.9%,P = 0.002),且随着MetS组分数量的增加而升高(P = 0.003)。此外,在对潜在风险因素进行调整后,MetS的存在(比值比2.43,95%置信区间1.39 - 4.26)以及更多的MetS组分数量与女性患者的DR显著相关。患有MetS的患者(多变量β系数,95%置信区间 - 6.9,- 10.0至 - 3.8)或更多的MetS组分数量往往具有显著更小的CRAE。
在本研究队列中,患有MetS的女性患者DR患病率更高。随着MetS组分数量的增加,患者的视网膜中央动脉往往更细。